Is FOXO Technologies Inc. (FOXO) a Buy, Sell, or Hold?
FOXO Technologies Inc.
AMEX:FOXO
$0.5157 USD
$0.0 (0.78%)
- Volume
- 2.86M
- Average Volume
- 48.29M
- Market Capitalization
- $9.01M
- P/E Ratio
- -0.72
- Dividend Yield
- 0.00%
- Price Target
- $
- Year High
- $1.30
- Year Low
- $0.13
- Payout Ratio
- $-0.43
- Current Ratio
- $0.08
Industry, Sector & symbol
| Stock Exchange | American Stock Exchange |
| CEO | Mr. Mark Brian White |
| Industry | Medical - Healthcare Information Services |
| Sector | Healthcare |
| Current Symbol | FOXO |
| CUSIP | None |
| CIK | 0001812360 |
| Web | https://www.foxotechnologies.com |
| Phone | 612-562-9447 |
| Currency | USD |
| Employees | 4 |
| Country | US |
Liquidity
| Debt-to-Equity Ratio | -0.76 |
| Payout Ratio | -0.43 |
| Current Ratio | 0.08 |
| Quick Ratio | 0.08 |
| Cash Ratio | 0.00 |
Sales & Book Value
| Annual Sales | $145K |
| Price / Sales | 6.40 |
| Cash Flow | -0.14 |
| Price / Cash Flow | -4.88 |
| Price / Book | -0.39 |
Price Target and Rating
| Average Stock Price Forecast | $ |
| High Stock Price Forecast | $ |
| Low Stock Price Forecast | $ |
| Forecast Upside/Downside | % |
| Consensus Rating | Sell |
| Rating Score(0-5) | 2 |
| Research Coverage | 0 Analysts |
Profitability
| EPS (Most Recent Fiscal Year) | $-7.08 |
| Trailing P/E Ratio | -0.72 |
| PEG Ratio | -0.02 |
| P/E Growth | -0.02 |
| Net Income | $-26.45M |
| Net Margin | -672.73% |
| Pretax Margin | -673.30% |
| Return on Equity | 60.45% |
| Return on Assets | -22.20% |
Financials Score
| AltmanZ Score | -7.37 |
| Piotroski Score | 4.00 |
| Working Capital | -31.44M |
| Total Assets | 42.67M |
| Ebit | -7.51M |
| Market Cap | 9.01M |
| Total Liabilities | 60.22M |
Poll Results
About FOXO Technologies Inc. (AMEX:FOXO) Stock
FOXO Technologies Inc., a technology platform company, focuses on commercializing longevity science through products and services that serve the life insurance industry. The company is developing products and services that combine longevity science with life insurance to support the consumer health and wellness engagement, and to simplify the consumer underwriting journey. It offers FOXO Labs, a services platform that integrates saliva-based epigenetic biomarkers into accelerated underwriting protocols to improve the customer underwriting journey; and FOXO Life, an insurance products platform that offers proprietary life insurance products and third-party life insurance carrier products based on bundling longevity science with life insurance. The company was founded in 2019 and is based in ... Minneapolis, Minnesota.
FOXO TECHNOLOGIES INC., CONFIRMS DETAILS OF SPECIAL MEETING OF SHAREHOLDERS ON NOVEMBER 29, 2024.
2024-11-25 11:15:00
MINNEAPOLIS, MN, Nov. 25, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), will hold its previously announced Special Meeting of its Shareholders at 10:30 am EST on Friday, November 29, 2024.
2024-08-08 08:30:00
MINNEAPOLIS, MN, Aug. 08, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company”), today announced that its recently acquired subsidiary, Myrtle Recovery Centers, Inc. (“Myrtle”), has been granted two full licenses from the Tennessee Department of Mental Health and Substance Abuse Services, effective August 1, 2024, for 12 months. The first license authorizes the provision of services for alcohol and drug residential detoxification treatment, as well as alcohol and drug residential rehabilitation treatment. The second license authorizes the provision of services for non-residential office-based opiate treatment.
2024-07-16 16:30:00
Reaffirms commitment to regaining compliance with the NYSE American continued listing standards Reaffirms commitment to regaining compliance with the NYSE American continued listing standards
2024-06-18 08:30:00
MINNEAPOLIS, MN, June 18, 2024 (GLOBE NEWSWIRE) -- FOXO Technologies Inc. (NYSE American: FOXO) (the “Company” or “FOXO”), today announced that it has secured up to $2.8 million in Senior Notes from an institutional investor (“Investor”) to fund the previously announced acquisition of Myrtle Recovery Centers, Inc. as well as provide additional working capital to support the Company's growth strategy.
2024-06-14 08:30:00
Acquisition expected to be synergistic with FOXO's epigenetic technology in community health and addiction recovery settings as well as contribute significant cash flow Acquisition expected to be synergistic with FOXO's epigenetic technology in community health and addiction recovery settings as well as contribute significant cash flow
Frequently Asked Questions
-
What is the current FOXO Technologies Inc. (FOXO) stock price?
-
FOXO Technologies Inc.(AMEX:FOXO) stock price is $0.5157 in the last trading session. During the trading session, FOXO stock reached the peak price of $1.3 while $0.13 was the lowest point it dropped to. The percentage change in FOXO stock occurred in the recent session was 0.78% while the dollar amount for the price change in FOXO stock was $0.0.
-
FOXO's industry and sector of operation?
-
The AMEX listed FOXO is part of Medical - Healthcare Information Services industry that operates in the broader Healthcare sector.
-
Who are the executives of FOXO?
-
Mr. Martin Christopher Ward FCA | Interim Chief Financial Officer
Mr. Mark Brian White | Interim Chief Executive Officer & Director
Mr. Jim Grauel Jr. | Chief Distribution Officer
Ms. Susan Neo | Chief Security Officer
| -
How many employees does FOXO have?
-
Number of FOXO employees currently stands at 4. FOXO operates from 729 North Washington Avenue, Minneapolis, MN 55401, US.
-
Link for FOXO official website?
-
Official Website of FOXO is: https://www.foxotechnologies.com
-
How do I contact FOXO?
-
FOXO could be contacted at phone #612-562-9447 and can also be accessed through its website. FOXO operates from 729 North Washington Avenue, Minneapolis, MN 55401, US.
-
How many shares of FOXO are traded daily?
-
The average number of FOXO shares traded daily for last 3 months was 48.29M.
-
What is the market cap of FOXO currently?
-
The market value of FOXO currently stands at $9.01M with its latest stock price at $0.5157